Highlighting a pipeline of investment and partnership opportunities, focused on addressing unmet needs in prostate cancer.
Proven Connect’s highly experienced leadership team and Translational Scientific Advisory Committee carry out rigorous due diligence on all companies that are included in our portfolio.
We ensure companies can demonstrate their commercial viability and technical rigour as well as their ability to meet a significant patient need.
Proven Connects wrap-around programme of support, in terms of mentorship, patient and clinical engagement and business advice, is designed to increase investors confidence in a companies ability to succeed.
Proven Connect will source a wide range of companies working in diagnostics, therapeutics and care of patients from our networks with pharma, CRO’s, TTO’s and other research organisations.
Explore opportunities with Proven
Interested in investing?
Current Investment Opportunities
These companies have satisfied our due diligence
Proven Connect is looking for impact investors who are seeking new investment opportunities in healthcare that have the clinical and commercial support of experts working in prostate cancer.
Dr Allan Marchington
Managing Director, Head of Life Sciences, Intermediate Capital Group